Relapse to opioid use disorder after inpatient treatment: Protective effect of injection naltrexone-Reference-Cited by-同舟云学术

Relapse to opioid use disorder after inpatient treatment: Protective effect of injection naltrexone

Published:2018-02 Issue: Volume:85 Page:49-55
ISSN:0740-5472
Container-title:Journal of Substance Abuse Treatment
language:en
Short-container-title:Journal of Substance Abuse Treatment

Author:

Nunes Edward V.,Gordon Michael,Friedmann Peter D.,Fishman Marc J.,Lee Joshua D.,Chen Donna T.,Hu Mei Chen,Boney Tamara Y.,Wilson Donna,O'Brien Charles P.

Funder

National Institute on Drug Abuse

Dana Foundation

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology,Medicine (miscellaneous),Pshychiatric Mental Health

Reference24 articles.

1. Release from prison—a high risk of death for former inmates;Binswanger;The New England Journal of Medicine,2007

2. Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996-99;Bird;Addiction,2003

3. Inpatient opiate detoxification in Geneva: Follow-up at 1 and 6 months;Broers;Drug and Alcohol Dependence,2000

4. Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: Efficacy of contingency management and significant other involvement;Carroll;Archives of General Psychiatry,2001

5. Contingency management to enhance naltrexone treatment of opioid dependence: A randomized clinical trial of reinforcement magnitude;Carroll;Experimental and Clinical Psychopharmacology,2002

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Approach to Enhancing Medication Treatment for Opioid Use Disorder in the HEALing Communities Study;Psychiatric Services;2024-06-01

2. The phenotype of recovery XI: associations of sleep quality and perceived stress with discounting and quality of life in substance use recovery;Quality of Life Research;2024-03-20

3. The relationships among withdrawal symptoms and depression in IV injection and non-injection groups in a population of heroin users;Heroin Addiction and Related Clinical Problems;2024-03

4. Pharmacological Treatment of Substance Use Disorders;Tasman’s Psychiatry;2024

5. Optimizing Retention Strategies for Opioid Use Disorder Pharmacotherapy: The Retention Phase of the Ctn-0100 Trial (RDD);2024